Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xeroderma pigmentosum.

Johannes Norgauer1, Marco Idzko, Elisabeth Panther

  • 1Department of Dermatology, University-Hospital, Hauptstr. 7, D-79104-Freiburg, Germany.

European Journal of Dermatology : EJD
|March 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.

Journal of clinical medicine·2026
Same author

Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer.

Cancer letters·2026
Same author

Primary pulmonary chondrosarcoma: clinical case and review of the literature.

Therapeutic advances in respiratory disease·2025
Same author

Transbronchial Cryobiopsy under Simultaneous Confocal Laser Endomicroscopy Guidance for Peripheral Pulmonary Lesions: A Pilot Study.

Respiration; international review of thoracic diseases·2025
Same author

The NEuroCOUGH Chronic Cough Registry: a protocol for a pan-European observational study.

ERJ open research·2025
Same author

How Should We Diagnose Dysfunctional Breathing in Severe Asthma?

The journal of allergy and clinical immunology. In practice·2025

Xeroderma pigmentosum (XP) is a rare genetic DNA repair disorder causing extreme sun sensitivity and early skin cancers. Topical DNA repair enzymes show promise, with gene therapy offering future treatment possibilities.

Area of Science:

  • Genetics
  • Dermatology
  • Molecular Biology

Background:

  • Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder.
  • It stems from a genetic defect in DNA repair mechanisms.
  • XP patients exhibit extreme sun sensitivity, leading to early-onset skin cancers like squamous cell carcinoma, basal cell carcinoma, and melanoma.

Purpose of the Study:

  • To summarize the genetic basis, clinical manifestations, and diagnostic approaches for Xeroderma pigmentosum.
  • To review current therapeutic strategies and explore future treatment avenues.

Main Methods:

  • Genetic classification into 7 complementation groups (XP-A to XP-G) and XP variants (XP-V).
  • Diagnostic assignment via fusioning of XP fibroblasts.
  • Differential diagnosis from similar DNA-repair-deficiency syndromes (e.g., Cockayne Syndrome, trichothiodystrophy).

Related Experiment Videos

Main Results:

  • XP patients develop severe sunburns and poikilodermia upon light exposure.
  • High incidence of skin cancers in childhood, often leading to early mortality due to metastases.
  • Successful application of topical DNA Repair Enzyme (recombinant liposomal encapsulated T4 endonuclease V) reported for repairing UV-induced cyclobutan-pyrimidine dimers.

Conclusions:

  • Xeroderma pigmentosum is a severe genetic disorder requiring careful diagnosis and management.
  • Topical DNA repair enzymes offer a current treatment option.
  • Gene therapy holds potential for future causal treatment of Xeroderma pigmentosum.